Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Fig 2

Research Article

Reversion of P-Glycoprotein-Mediated Multidrug Resistance in Human Leukemic Cell Line by Diallyl Trisulfide

Figure 2

Concentration of adriamycin in K562 or K562/A02 cells.
(a) K562 cells
(b) K562/A02 cells
(c) K562 cells + ADM (adriamycin)
(d) K562/A02 cells + ADM (adriamycin)
(e) K562/A02 cells + DATS + ADM (adriamycin)
(f) K562/A02 cells + VRP (verapamil) + ADM (adriamycin)
(g) K562/A02 cells were treated with DATS (2 μmol/L) or verapamil (4  ) for 48 h, then adriamycin (5  ) was added and coincubated for a further 2 h

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.